When does emicizumab’s patent expire?
The exact expiration date depends on which jurisdiction (country) and which specific patents are being used to protect emicizumab (Hemlibra). Patent coverage can run beyond the first filed patents due to multiple filings, “patent term adjustments,” and extensions.
What makes emicizumab’s patent timeline complicated?
Emicizumab is protected by a portfolio of patent families rather than a single patent. That means different patents can expire at different times, and regulators may also grant additional protection tied to the first marketing authorization and local patent-extension rules.
Do patents expire all at once, or does generic/biosimilar entry wait for the last one?
Generic versions of a protein drug like emicizumab are typically not direct “generics.” Instead, the key question is when biosimilar/biobetter competition can enter without infringing the still-in-force patents. In practice, that often means market entry timing can be driven by the latest-expiring, most-enforced patents (or a successful patent challenge/settlement).
How do “exclusivity” periods differ from patent expiration?
Even after patent claims expire, countries can still offer market exclusivity periods that delay competitors. Those exclusivity periods are separate from patents and vary by region, so “patent expiration” alone may not predict when competition starts.
What happens if competitors launch before patent expiry?
If a biosimilar or other competitor launches while relevant patents are still in force, the product can trigger infringement litigation and potential court orders restricting sales (or requiring design-arounds). Timing often reflects both legal outcomes and the risk tolerance of the manufacturer.
Which regions should you check for emicizumab patent expiry?
If you are trying to pinpoint a date, you generally need to check patent status in the country where you care about market entry (for example, the US, EU, UK, Japan, or other national markets). Patent databases and legal registries in each region provide the “in force / expired / challenged” status that determines realistic timelines.
If you tell me your country, I can narrow to the likely expiry window
Patent expiry dates are jurisdiction-specific. Share the country (and, if relevant, whether you mean the US, EU, UK, or Japan), and I can map the likely expiry window based on the patents that are typically most relevant for market protection.
Sources
No sources were provided in the prompt, so I can’t cite a specific expiration date or patent number. If you paste a link to the patent record or the jurisdiction you care about, I can translate it into a clear expiry timeline.